Systemic and Topical PUVA Therapy

Therapy of Moderate-to-Severe Psoriasis, Second Edition, Revised and Expanded

Volumn , Issue , 2003, Pages 91-114

  Morison, Warwick L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10844235760     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14220-8     Document Type: Chapter

References (45)

1. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet. N Engl J Med 1974;291:1207-1211.
2. Morison WL. Phototherapy and Photochemotherapy of Skin Disease. 2nd ed. New York, NY: Raven Press, 1991.
3. Abel EA. Photochemotherapy in Dermatology. New York: Igaku-Shoin, 1992.
4. Guidelines of care for phototherapy and photochemotherapy. J Am Acad Dermatol. 1994;31:643-648.
5. Farr PM, Diffey BL, Higgins EM, Matthews JNS. The action spectrum between 320 and 400nm for clearance of psoriasis by psoralen photochemotherapy. Br J Dermatol. 1991;124:443-448.
6. Parrish JA, White AD, Kingsbury T, Zahar M, Fitzpatrick TB. Photochemotherapy of psoriasis using methoxsalen and sunlight. Arch Dermatol. 1977;133:1529-1532.
7. Wolff K, Gschnait F, Honigsmann H, Konrad K, Parrish JA, Fitzpatrick TB. Phototesting and dosimetry for photochemotherapy. Br J Dermatol. 1977;96: 1-10.
8. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL, and 28 participating investigators. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol. 1977;68:328-335.
9. Momtaz-TK, Parrish JA. Combination of psoralens and ultraviolet A and ultraviolet B in the treatment of psoriasis vulgaris: a bilateral comparison study. J Am Acad Dermatol. 1984;10:481-486.
10. Fritch PO, Honigsmann H, Jaschke E, Wolff K. Augmentation of oral methoxsalen–photochemotherapy with an oral retinoic acid derivative. J Invest Dermatol. 1978;70:178-182.
11. Parker S, Coburn P, Lawrence C, Marks J, Shuster S. A randomized doubleblind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. Br J Dermatol. 1984;110:215-220.
12. Honigsmann H, Wolff K. Isotretinoin-PUVA for psoriasis. Lancet. 1983;1:236.
13. Morison WL, Momtaz K, Parrish JA, Fitzpatrick TB. Combined methotrexate PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol. 1982; 6:46-51.
14. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB, and 22 participating investigators. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Eng J Med. 1979;300:809-813.
15. Stern RS, Lange R, and members of the photochemotherapy follow-up study. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988;91:120-124.
16. Henseler T, Christophers E, Honigsmann H, Wolff K, and 19 other investigators. Skin tumors in the European PUVA study. J Am Acad Dermatol. 1987;16:108-116.
17. Stern RS, and members of the photochemotherapy follow-up study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med. 1990;322:1093-1097.
18. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and cyclosporin: nested cohort crossover study. Lancet. 2001;358:1042-1045.
19. Stern RS. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001;44:755-761.
20. Stern RS, Parrish JA, Fitzpatrick TB. Ocular findings in patients treated with PUVA. J Invest Dermatol. 1985;85:269-273.
21. Fischer T, Alsins J. Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Dermatovener (Stockh) 1976;56:383-390.
22. Hannuksela M, Karvonen J. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis. Br J Dermatol. 1978;99:703-707.
23. Coven T, Murphy F, Gilleaudeau P, Cardinale I, Krueger J. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Arch Dermatol. 1998;134:1263-1268.
24. Neumann N J, Kerscher M, Ruzicka T, Lehmann P. Evaluation of PUVA bath phototoxicity. Acta Derm Venereol (Stockholm). 1997;77:385-387.
25. Gruss C, Behrens S, Reuther T, Husebo L, Neumann N, Altmeyer P, Lehmann P, Kerscher M. Kinetics of photosensitivity in bath-PUVA photochemotherapy. J Am Acad Dermatol. 1998;39:443-446.
26. Meffert H, Andersen K, Sonnichsen N. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time. Photodermatology 1984;1:191-194.
27. Gange RW, Levins P, Murray J, Anderson RR, Parrish J A. Prolonged skin photosensitization induced by methoxsalen and subphototoxic UVA irradiation. J Invest Dermatol. 1984;82:219-222.
28. Diffey B. Time course of activity of topical 8-methoxypsoralen. Br J Dermatol. 1992;127:654-659.
29. Koulu L, Jansen C. Skin phototoxicity variations during repeated bath PUVA exposures to 8-methoxpsoralen and trimethylpsoralen. Clin Exp Dermatol. 1984;9:64-69.
30. Dolezal E, Seeber A, Honigsmann H, Tanew A. Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA. Photodermatol Photoimmunol Photomed. 2000;16:183-185.
31. Gomez M, Azana J, Arranz I, Harto A, Ledo A. Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: relationship to disease severity. Br J Dermatol. 1995;133:37-40.
32. Hallman C, Koo J, Omohundro C, Lee J. Plasma levels of 8-methoxypsoralen after topical paint PUVA on nonpalmoplantar psoriatic skin. J Am Acad Dermatol. 1994;31:273-275.
33. Cripps D, Lowe N, Lerner A. Action spectra of topical psoralens: a reevaluation. Br J Dermatol. 1982;107:77-82.
34. Ortel B, Perl S, Kinaciyan T, Calzavara-Pinton P, Honigsmann H. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol. 1993;29:736-740.
35. Vallat V, Battat L, Heftler N, Hodak E, Krueger J. PUVA bath therapy with 8-methoxypsoralen. In: Weinstein GD, Gottlieb AB, eds. Therapy of Moderateto-Severe Psoriasis. Portland, OR: National Psoriasis Foundation, 1994:39-55.
36. Lowe N, Weingarten D, Bourget T, Moy L. PUVA therapy for psoriasis: Comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol. 1986;14:754-760.
37. Tanew A, Kipfelsperger T, Seeber A, Radakovic-Fijan S, Honigsmann H. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment. J Am Acad Dermatol 2001;44:638-642.
38. Schiener R, Behrens-Williams S, Pillekamp H, Peter R, Kerscher M. Does the minimal phototoxic dose after 8-methoxypsoralen baths correlate with the individual’s skin phototype? Photodermatol Photoimmunol Photomed. 2001;17:156-158.
39. Grundmann-Kellmann M, Behrens S, Peter R, Kerscher M. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed. 1999; 15:87-89.
40. Taylor C, Baron E. Hand and foot PUVA soaks: an audit of the Massachusetts General Hospital’s experience from 1994 to 1998. Photodermatol Photoimmunol Photomed. 1999;15:188-192.
41. Grundmann-Kollmann M, Tegeder I, Ochsendorf F, Zollner T, Ludwig R, Kaufmann R, Podda M. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations. Br J Dermatol. 2001;144:991-995.
42. Berne B, Fischer T, Michaelsson G, Noren P. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients. Photodermatology. 1984;1:18-22.
43. Lindelof B, Sigurgeirsson B, Tegner E, Larko O, Berne B. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. Arch Dermatol. 1992;128:1341-1344.
44. Hannuksela A, Pukkala E, Hannuksela M, Karvonen J. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. J Am Acad Dermatol 1996;35:685-689.
45. Hannuksela M, Stenback F, Lahti A. The carcinogenic properties of topical PUVA. Arch Dermatol Res. 1986;278:347-351.